MetaCap

Kestra Medical Technologies (KMTS) vs LeMaitre Vascular (LMAT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Kestra Medical Technologies (KMTS) has outperformed LeMaitre Vascular (LMAT) over the past year, losing 3.8% versus a loss of 16.3%. LeMaitre Vascular is the larger company by market cap ($1.68 billion vs $1.50 billion), about 1.1 times the size, while Kestra Medical Technologies is growing revenue faster (+59.0% vs +13.5%). LeMaitre Vascular pays a dividend yielding 1.29%, while Kestra Medical Technologies does not currently pay one.

LeMaitre Vascular converts more of its revenue into profit, with a net margin of 23.1% versus -138.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KMTS-3.79%LMAT-16.29%
+37%+1%-35%
Nov 21, 20251 yearNov 20, 2026
KMTS+19.58%LMAT-9.54%
+45%+5%-34%
Mar 3, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KMTS versus LMAT key metrics
MetricKMTSLMAT
Share price$25.10$73.61
Market cap$1.50B$1.68B
1-day change-5.75%-1.67%
YTD return-5.35%-9.24%
1-year return-3.79%-16.29%
5-year return—+50.96%
P/E ratio (TTM)—26.77
Forward P/E—23.37
EPS (TTM)$-2.67$2.75
Dividend yield0.00%1.29%
Annual dividend$0.00$0.95
Revenue (latest FY)$95.13M$249.60M
Revenue growth (YoY)+59.03%+13.53%
Net income (latest FY)$-131.61M$57.73M
Gross margin51.37%71.53%
Operating margin-141.64%27.21%
Net margin-138.36%23.13%
52-week high$31.99$118.01
52-week low$17.34$73.44
Distance from 52-week high-21.54%-37.62%
Analyst consensusstrong_buybuy
Avg. price target upside+24.02%+34.89%
Average volume418.09K277.19K
Shares outstanding59.56M22.88M
Employees443646
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • KMTS has outperformed LMAT by 12.5 percentage points over the past year.
  • LeMaitre Vascular offers a meaningfully higher dividend yield (1.29% vs 0.00%).
  • LeMaitre Vascular is more profitable, keeping 23.1 cents of every revenue dollar as net income versus -138.4 cents for Kestra Medical Technologies.
  • Kestra Medical Technologies grew revenue faster in its latest fiscal year (+59.03% vs +13.53%).

About Kestra Medical Technologies

KMTS stock →

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

Health Care · Medical/Dental Instruments · 443 employees

About LeMaitre Vascular

LMAT stock →

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.

Health Care · Medical/Dental Instruments · 646 employees

KMTS vs LMAT FAQ

Which is bigger, Kestra Medical Technologies or LeMaitre Vascular?

LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.68B compared with $1.50B for Kestra Medical Technologies (KMTS).

Which stock has performed better over the past year, KMTS or LMAT?

KMTS returned -3.79% over the past 12 months, compared with -16.29% for LMAT (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Kestra Medical Technologies or LeMaitre Vascular?

LeMaitre Vascular pays a dividend yielding 1.29%, while Kestra Medical Technologies does not currently pay a regular dividend.

Are Kestra Medical Technologies and LeMaitre Vascular in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons